throbber
it ”0
`M k: NATIONAL CHILDHOOD CANCER FOUNDATION
`ar
`Serial No; 76/105,918
`
`Docket: T04397USO
`
`llllllllll
`lllllllllllllllll\lllllllzlllgllllgllllol
`7-26
`1
`0
`U 5 Patent & TMOfoITM Mail Rem. Dr. #3
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Mark: NATIONAL CHILDHOOD CANCER
`FOUNDATION
`
`Examining Attorney:
`Michael E. Bodson
`
`Applicant: National Childhood Cancer Foundation
`
`Law Office: 1 10
`
`Sena] No.1 76/105,918
`
`Filed: August 8, 2000
`
`Class: 36
`
`Box RESPONSES
`NO FEE
`Assistant Commissioner for Trademarks
`
`CERTIFICATIONUNDER 37 CFR§ 1.8
`I hereby certify that the documents referred to as enclosed herein are being
`deposited with the United States Postal Service as first class mmn this
`date July 23 mm in an envelope addressed In Box REsponsss No
`FEE, Assistant Commissioner for Trademarks, ZEQQCrystal DEE
`Arlington, VA 222023513
`s
`
`
`4
`
`3
`
`v
`
`303291;?wa
`ignature
`
`
`
`2900 Crystal Drive
`Arlington, VA 22202-3513
`
`Dear Sir:
`
`RESPONSE TO OFFICE ACTION
`
`This communication is in response to the Office Action mailed January 23, 2001,
`
`whereby the Examining Attorney set forth the following:
`
`1.
`
`Registration on the Principal Register is refused on the grounds that the
`
`proposed mark merely describes the services.
`
`Gray Cary\SD\l 456804
`67276—900001
`
`1
`
`

`

`REMARKS
`
`The Examining Attorney has refused the Applicant’s application arguing that the
`
`subject mark is merely descriptive. Applicant respectfully disagrees with the rejection for the
`
`following reasons:
`
`I. Applicant’s mark has Acquired Distinctiveness
`
`Applicant submits that the subject mark has acquired a secondary meaning. A merely
`
`descriptive term may be registered and protected if that term has acquired a secondary meaning
`
`in its particular market. Pursuant to Section 2(1), the Director may accept as primafacz'e evidence
`
`that the mark has become distinctive, “proof of substantially exclusive and continuous use thereof as
`
`a mark by the applicant in commerce for the five years before the date on which the claim of
`
`distinctiveness is made.”
`
`Secondary meaning or acquired distinctiveness requires that the consuming public
`
`primarily associates the term with a particular source. Bristol-Myers Squibb Co. v. McNeil-
`
`P.P.C., Inc, 973 F.2d 1033, 1040 (2nd Cir. 1992). Secondary meaning may be measured using a
`
`variety of factors. Those factors considered include, the manner and length of use of the mark,
`
`the nature and extent of advertising and promotion thereunder, the steps taken by applicant to
`
`create in the minds of the purchasing public a conscious association of the mark with the
`
`particular goods or services, and the results of these efforts. In re Instant Transactions Corp. of
`
`America, 201 U.S.P.Q. 957, 958 (TTAB 1979).
`
`Gray Cary\SD\l456804
`67276-900001
`
`2
`
`

`

`A.
`
`Length and Exclusivity of Use
`
`Applicant has used this mark substantially exclusively and continuously since
`
`May 1992, which is greater than the five year period required under Section 2(0. See
`
`Declaration of Robert L. Pannoni, attached hereto as Exhibit A, (“Pannoni Decl.”), pg. 1, para. 2.
`
`Further, extensive marketing and advertising have taken place and the Applicant
`
`has raised millions of dollars in donations. Therefore, given the length and extent of use (more
`
`fully explained below), the Applicant respectfully submits that the NATIONAL CHILDHOOD
`
`CANCER FOUNDATION mark has acquired a secondary meaning.
`
`B.
`
`Nature and Extent of Advertising
`
`Advertising and promotion expenditures can be relevant evidence from which to
`
`infer the creation of secondary meaning in the minds of the public. In re Andes Candies Inc,
`
`478 F.2d at 1267. Applicant has spent more than $550,000 on advertising and publication
`
`expenses from/1993 to present. (Pannoni Decl., pg.2 , para. 3).
`
`In addition, Applicant publishes a quarterly newsletter, Childhood Cancerline, for
`
`donors and other interested parties as well as an Annual Report and Honor Roll of Donors, all of
`
`which prominently display Applicant’s mark. This newsletter has widespread distribution and
`
`has reached thousands of consumers since its launch in 1994. (Pannoni Decl., pg. 2, para. 4)
`
`Since 1994, Applicant has also advertised in numerous national publications
`
`including Martha Stewart Living, Fart Campbell Courier, Neoplasia, The Optimist, Scientific
`
`American and was recognized as a beneficiary of the 1994 Shark Shootout hosted by golf
`
`professional Greg Norman. (Pannoni Decl., pg. 2 , para. 5)
`
`Gray Cary\SD\1456804
`67276-900001
`
`3
`
`

`

`In addition to these significant advertising and marketing expenditures, the
`
`Applicant operates a website which prominently displays the NATIONAL CHILDHOOD
`
`CANCER FOUNDATION mark directly in connection with the Applicant’s charitable
`
`fundraising services. Through this website, consumers throughout the United States and the
`
`world have been exposed to the NATIONAL CHILDHOOD CANCER FOUNDATION mark
`
`since the website launch date of 1995. Although historical Visitor data is not available, in the
`
`month of May 2001 alone, the Applicant’s website had a total of 632,305 successful hits which
`
`translates to an average of in excess of 20,000 hits per day. Extrapolated over the six year period
`
`from 1995, this equates to millions of Visitors who were exposed to the Applicant’s mark.
`
`(Pannoni Decl., pg. 2-3, para. 6)
`
`C.
`
`Sales - Number of Donors and Total Amount of Funds raised.
`
`Sales information can be relevant evidence from which to infer the creation of
`
`secondary meaning. In re Andes Candies Inc., 478 F.2d 1264, 1267 (C.C.P.A. 1973). In the
`
`instant matter, a donation is a “sale” of the Applicant’s services, which are charitable fundraising
`
`services. Cost of the product and the length of time over which sales took place [number of
`
`donations, total funds raised and the number of years] must be taken into account when inferring
`
`secondary meaning from sales figures. In re Ideal Industries, Inc., 508 F.2d 1336, 1339
`
`(C.C.P.A. 1975). In the instant case, since 1992, Applicant has received donations from nearly
`
`23,000 donors representing all 50 states, the District of Columbia and several foreign countries.
`
`In this same time frame, the National Childhood Cancer Foundation has raised close to
`
`$100,000,000 (100 Million Dollars) due to its fundraising efforts. This represents significant
`
`consumer recognition of the subject mark and association of this mark with the Applicant.
`
`(Pannoni Decl, pg. 3, para. 7)
`
`Gray Cary\SD\1456804
`67276-900001
`
`4
`
`

`

`Equally significant is the number of organizations which have received grants and
`
`funds since 1992. For example, the list for 1999 shows in excess of 175 hospitals, medical
`
`clinics, universities, and research institutes that have received in excess of $8,500,000. These
`
`numbers together with the number of donors demonstrates that consumers both on the giving and
`
`receiving ends have had substantial exposure to the NATIONAL CHILDHOOD CANCER
`
`FOUNDATION mark in the Applicant’s arena, thus supporting a finding of acquired
`
`distinctiveness. (Pannoni Decl., pg. 3, para. 8)
`
`D.
`
`Customer testimony/letters
`
`Letters and/or testimony by consumers expressing their understanding of the mark
`
`at issue is direct evidence of consumers’ associations with Applicant’s mark and leads to a
`
`finding of acquired distinctiveness. Loctite, 516 F. Supp. at 204. Consumers who identify the
`
`mark as belonging to the producer, rather than any other company in the field, demonstrate an
`
`acquired distinctiveness of that mark. Schenectady Varnish, 280 F.2d at 1158. Attached as
`
`Exhibit 7 to the Pannoni Decl. are testimonials from 9 National Childhood Cancer Foundation
`
`donors and/or volunteers attesting to their familiarity with the NATIONAL CHILDHOOD
`
`CANCER FOUNDATION mark with the Applicant and evidencing that they believe the
`
`Applicant to be the source of the fimdraising activities bearing this mark.
`
`By virtue of the extensive dollar amount of funds raised [i.e. sales], the number of
`
`donors and the widespread geographic area of the donors, the number of organizations receiving
`
`grants, the amount of marketing and advertising expenditures, and the widespread distribution of the
`
`CHILDHOOD CANCERLINE newsletter, all of which display the NATIONAL CHILDHOOD
`
`CANCER FOUNDATION mark in strictly a trademark sense to indicate the source of its charitable
`
`Gray Cary\SD\l456804
`67276-900001
`
`5
`
`

`

`fundraising, it is respectfully submitted that Applicant’s mark has acquired distinctiveness under
`
`Section 2(i).
`
`CONCLUSION
`
`In View of the foregoing remarks, it is believed that this Application is in
`
`condition for prompt publication. Favorable action is therefore requested.
`
`Respectfully submitted,
`
`Dated: July E, 2001
`
`John M. Kim, Esq.
`GRAY CARY WARE & FREIDENRICH LLP
`
`401 B Street, Suite 1700
`San Diego, California 92101-4297
`Telephone:
`(619) 699—2659
`Facsimile:
`(619) 699-2701
`
`Gray Cary\SD\1456804
`67276-900001
`
`6
`
`

`

`Mark: NATIONAL CHILDHOOD CANCER FOUNDATION
`Serial No.2 76/105,918
`Docket: T043 97USO
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Mark: NATIONAL CHILDHOOD CANCER FOUNDATION
`
`Applicant: National Childhood Cancer Foundation
`
`Serial No.: 76/105,918
`
`Filed: August 8, 2000
`
`Class: 36
`
`
`
`BOX RESPONSES
`NO FEE
`Assistant Commissioner for Trademarks
`
`2900 Crystal Drive
`Arlington, VA 22202-3 513
`
`DECLARATION OF ROBERT L. PANNONI
`
`IN SUPPORT OF ACQUIRED DISTINCTIVENESS
`
`1, Robert 1. Pannoni, declare as follows:
`
`1.
`
`I am the interim CEO/COO of the National Childhood Cancer Foundation
`
`(“Applicant”). 1 have been the C00 since August 1, 1991. I am familiar with all areas of the
`
`National Childhood Cancer Foundation’s operations, including but not limited to the matters
`
`stated herein.
`
`2.
`
`The Applicant has had substantially exclusive and continuous use in commerce of
`
`its NATIONAL CHILDHOOD CANCER FOUNDATION mark for charitable fundraising
`
`services as described in its application, since at least as early as May 1992.
`
`Gray Cary\SD\l457l31
`67276-90000]
`
`1
`
`

`

`3.
`
`Since 1993, Applicant has spent more than $570,000 in advertising and
`
`publication expenditures to promote the NATIONAL CHILDHOOD CANCER FOUNDATION
`
`mark. Attached hereto as Exhibit 1 is a true and correct copy of a listing, by year, of Applicant’s
`
`advertising and publication expenses.
`
`4.
`
`Applicant publishes a quarterly newsletter, Childhood Cancerline, for donors and
`
`other interested parties as well as an Annual Report and Honor Roll of Donors, both of which
`
`prominently display Applicant’s mark. This newsletter has widespread distribution and has
`
`reached thousands of consumers since its inception in 1994. Attached hereto as Exhibit 2 are
`
`several issues of Childhood Cancerline [formerly Heartbeat] dating from as early as November
`
`1994.
`
`5.
`
`Since at least as early as 1994, Applicant has advertised in numerous publications
`
`nationwide including Martha Stewart Living, Fort Campbell Courier, Neoplasia, The Optimist,
`
`Scientific American and was recognized as a beneficiary of the 1994 Shark Shootout hosted by
`
`golfprofessional Greg Norman. True and correct copies of such advertisements are attached
`
`hereto as Exhibit 3.
`
`6.
`
`Applicant operates a website which prominently displays the NATIONAL
`
`CHILDHOOD CANCER FOUNDATION mark directly in connection with the Applicant’s
`
`charitable fundraising services. Through this website, consumers throughout the United States
`
`and the world have been exposed to the NATIONAL CHILDHOOD CANCER FOUNDATION
`
`mark since the website launch date of 1995. Although historical visitor data is not available, in
`
`the month of May 2001 alone, the Applicant’s website had a total of 632,305 successful hits
`
`which translates to an average of in excess of 20,000 hits per day. If this figure is extrapolated
`
`over the six year period from 1995, this would equate to millions of website visitors. Attached
`
`Gray Cary\SD\1457131
`67276-900001
`
`2
`
`

`

`hereto as Exhibit 4 is a true and correct copy of a print out of the home page and several other
`
`pages from the website which describe and promote the Applicant’s services under the
`
`NATIONAL CHILDHOOD CANCER FOUNDATION mark and statistical information
`
`regarding visitor information to the Applicant’s website in May 2001.
`
`7.
`
`Since 1992, Applicant has received donations from nearly 23,000 donors
`
`representing all 50 states, the District of Columbia and several foreign countries. In this same
`
`time frame, the National Childhood Cancer Foundation has raised close to $100,000,000 due to
`
`its fundraising efforts. This represents significant consumer recognition of the subject mark and
`
`association of this mark with the Applicant. Attached hereto as Exhibit 5 is a true and correct
`
`copy of a listing, by year, of total revenue received and a chart showing the number of donors by
`
`location.
`
`8.
`
`Since 1992, Applicant has awarded grants and funds to numerous organizations.
`
`The list for 1999, for example, shows that more than 175 hospitals, medical clinics, universities,
`
`and research institutes nationwide received in excess of 38,5 00,000. These numbers together
`
`with the number of donors demonstrates that consumers have had substantial exposure to the
`
`NATIONAL CHILDHOOD CANCER FOUNDATION mark. Attached hereto as Exhibit 6 is a
`
`true and correct copy of a listing, by year, of total funds disbursed to institutions and yearly
`
`listings of all institutions which have received funds from the Applicant.
`
`9.
`
`Numerous customers have come to recognize the NATIONAL CHILDHOOD
`
`CANCER FOUNDATION mark as originating fiom the Applicant and identifying the
`
`Applicant’s charitable fundraising services. Attached hereto as Exhibit 7 are testimonials from 9
`
`National Childhood Cancer Foundation donors and/or volunteers attesting to their familiarity
`
`with the NATIONAL CHILDHOOD CANCER FOUNDATION mark with the Applicant and
`
`Gray Cary\SD\l457131
`67276-900001
`
`3
`
`

`

`evidencing that they believe the Applicant to be the source of the fundraising activities bearing
`
`this mark.
`
`10.
`
`I believe that as a result of these marketing and promotional efforts, the number
`
`and widespread location of donors and the substantially exclusive and continuous use in
`
`commerce on the services claimed in the Applicant’s application for the 9 years before the date
`
`of this Statement, the NATIONAL CHILDHOOD CANCER FOUNDATION mark has become
`
`distinctive of the Applicant’s services.
`
`Gray Cary\SD\l457l31
`67276-900001
`
`4
`
`

`

`Jul 20 31 03:19p
`- —— *~'fl1”20.2821_‘223ym
`
`no.451
`
`P.6
`
`11.
`
`The above Statements made with my own knowledge are true and all statements
`
`made on information and belief are believed to be true. The statements were made with the
`
`knowledge that willful false statements and the like are punishable by fine or imprisonment, or
`
`both, under Section 1001 of Title 18 of the United Slams Code, and that such willful false
`
`statements may jeopardize the validity of this application and any registration resulting
`
`therefrom.
`
`«A
`Executed this 20' day ofJuly,2001,at flag/)4
`
`.Califomia.
`
`National Childhood Cancer Foundation
`
`Robert L. Famoni
`Interim CEO/COO
`
`Gny CIry\SD\MS7 I31
`67276-900001
`
`5
`
`RECEIVED TIME
`
`JUL.2@.
`
`3511PM
`
`PRINT TIME
`
`JUL.EB.
`
`3:15PM
`
`

`

`

`

`NATIONAL CHILDHOOD CANCER FOUNDATION
`
`ADVERTISING - PUBLICATION EXPENSES
`
`FOR YEARS 1993-2000
`
`1993
`1994
`1995
`1996
`1997
`1998
`1999
`2000
`
`TOTAL
`
`'
`
`.
`
`$1,759
`$9,801
`$95,993
`$103,513
`$63,585
`$73,019
`$96,062
`$130,075
`
`$573,807
`
`

`

`

`

`
`
`
`
`
`
`
`
`FOUNDATIONTM
`
`"Baywatch" Beauty
`
`' Had a Bout With
`
`Cancer As a Child
`eautiful
`in her sleek swimsuit,
`cavorting on a Hawaiian beach in
`front of the “Baywatch" cum—
`signing autographs
`seeing
`eras,
`Melody-Lynette Lomboy like this, it is
`hard to imagine the three tough years
`she spent as a child, fighting leukemia.
`She was the baby of five children,
`growing up in sunny Southern California,
`swimming at
`the local pool, singing
`with the family band. Then one day
`when her mother was fixing the six-
`year-old’s hair for school, she noticed a
`lump on the side of her neck.
`A pediatrician told her there was
`nothing unusual
`in the bloodstream
`“But my mom is Italian and hard—head-
`ed,” says Melody, “and she insisted on a
`referral to a cancer center.” There the
`doctors found leukemia cells in the
`
`child’s spinal fluid and bone marrow.
`Melody began three years of intense
`chemotherapy. Her hair fell out, grew
`back in, and fell out again, several times.
`But she went right on with her school-
`work and her competitive swimming.
`“I’d have chemo on Friday, be sick
`all night, and then get up Saturday and
`race.
`I was so young,
`it didn’t seem
`unusual to me,” she recalls.
`
`
`
`
`
`
`
`
`MEANT TO BE A STAR ‘ Cancer survivor Melody
`Lynette Lomhoy appeared in a featured role on a
`recent episode of “Baywatch Hawaii.”
`
`— Zontinued on page 2
`
`
`
`
`Meet the Man Guiding The Future of
`Childhood Cancer Research
`
`
`
`
`Gregory Reaman, M.D.
`Chair, Children' 3
`Oncology Group (C.0.G.)
`
`regory Rearnan, M.D., has been
`elected Chair of the Children’s
`Oncology Group (C.O.G.) The
`member—institutions of this cooperative
`research network, recently formed by the
`merger of four national childhood cancer
`research and treatment groups,
`are
`responsible for the care of more than
`90% of the children with cancer in North
`America. The Group develops and coor-
`dinates clinical trials conducted at over
`235 children’s hospitals. university hos—
`pitals and cancer centers throughout the
`US and Canada, as well as at sites in
`Europe and Australia.
`is that our
`“My vision for C.O.G.
`unity of membership, purpose, and mis—
`sion will result in an environment that
`will lead to even greater and more irnrne
`diate benefits for children with cancer,”
`says Dr. Reaman. “Collaboration at
`every level is essential for scientific dis—
`covery, which originates from the best
`
`validated concepts and will translate into
`advances in care."
`Dr. Reaman serves as both Executive
`Director of the Center for Cancer and
`Blood Disorders, and Chair of the divi—
`sion of Hematology-Oncology, at
`the
`Children’s National Medical Center in
`Washington DC. He is professor of»
`pediatrics
`at George Washington
`University School of Medicine and
`Health Sciences.
`Since l990 he has served on the
`Board of Trustees of
`the National
`Childhood Cancer Foundation (NCCF),
`the grantee and fundraising organization
`for C.O.G. He says he wants to work
`through the foundation, “To secure the
`financial support we need to achieve our
`mission, adequately funding those oper—
`ations and resources that are essential to
`our success.”
`The Children’s Oncology Group is
`currently hard at work preparing the first
`competing grant application for
`the
`National Cancer Institute, which will be
`submitted in February of 2002. Future
`goals of C.O.G.
`include increased sur«
`vivor
`follow—up, more teenagers with
`— Continued on page 3
`
`
`
`Don't forget —
`September is
`Childhood Cancer
`
`Month!
`Start planning now for ways you can help
`spread awareness of childhood cancer
`and advocate on behalf of the infants,
`children, teens and young adults fighting
`the disease in September. For informa—
`tion on Childhood Cancer Gold Ribbon
`
`to be held in Washington DC,
`Days,
`check out the websites www.nccf.org and
`www,ChildhoodCancerAwareness.org.
`
`
`
`

`

`
`
`-
`
`,
`
`Pharmae1sts Play Important Rolein Treating KidsWith Cancer
`vent small problems from becoming large problems,” says
`ithin the Children’s Oncology Group (C.O.G.) thereis
`Sorenson.
`-
`.
`_
`.
`.
`,
`,-
`a network of over 100 pharmacists who are working
`When a childis receiving medication as an out—patient, the
`with pediatric oncology patients all across North
`pharmacist must also teach the family how to administer the
`America and in Australia Thirty of them serve on the
`medications at home, which might include making up a med—g
`Pharmacy Committee of C. O.G. and meet in person at least
`ication calendar so that doses are given 7;
`twice a year at C. O. G. meetings or
`
`'atthe right times.
`if the family lives.
`other pharmacy meetings.
`, some distance from the hespitai',_ and‘is
`The goal of. Mark K. Sorenson,
`
`Chair of the Pharmacy Committee, is to
`using‘local. providers,
`the pharmacist
`
`may have to be in touch with the local
`get pharmacists involved in childhood
`
`
`pharmacy to coordinate the drug, thera-
`cancer protocols while they are in
`
`py. AcCording to sorensoni “The phar-
`development,
`to enSure that the drug
`i‘macist
`really pulls
`all?
`the players
`therapy elements will answer the study
`question, and to enhance the safety of
`together, particularly in the home care
`situation.”
`'
`‘
`the protocol.
`For many new drugs,
`With the'mercaSing coSts of health—
`there is little information available on
`carc, pharmacists become involved in’
`pediatric use of the drug, and the phar—
`the cost of drugs; Iftwo drugs. are equiv— »
`macist can help determine the dose of
`alent, the pharmacist can suggeSt.
`the:
`‘
`the drugs for trials for children.
`most cost-effective. However, he points
`Pharmacists prepare the Drug Mono—
`, ut,f,“S‘ometirnes it is less expensive [in ,
`graph, which becomes a part of the
`the long run to use. a,more.expensi=ye ‘
`Pharmacist Mark K Sorensyon of‘thekUniVersity. of lowa _
`protocol itself. This detailed document
`
`’iospitals and Clinicsis Chair or the Pharmacy
`drug, particularly if it preVents' hospital<
`includes eVerything the healthcare team "
`Committee of the Children's Oncology Group (C.0G)
`might need to know, including how to
`ization days.’7 Most difficult to quantify ,
`
`
`are the quality of life issues. If an,
`_
`administer the drug, what it is compati-
`expensive drug will prevent a child from vomiting for days
`ble with, the side effects, and how to obtain it.
`Medication delivery is a large part of the work for a phar-
`after chemotherapy, he asks, ‘tWhat kind of price canyouput
`on that?”

`~
`-
`macist in a pediatric oncology setting. This includes prepar—
`Clearly the pharmacist plays an important rolein the multi—
`ing the medications for in-patients, and meeting with patients
`disciplinary team approach to caring for children: with cancer
`and their families to answer questions about drug interactions,
`' Sorenson says he sees. the care of the child with cancer as apie. '
`allergies, how to minimize adverse effects. of the drugs, and
`how to administer the drug so the child will take it. (For exam—
`“With the physician, the nurse, the physical therapist, the phar—_'
`macist, and all the other healthcare- players each having a big
`ple, if the child doesn’t like the taste, breaking a tablet and hid-
`piece. Take one away, and you still maybe able to’treat the
`ing it inside a gelatineapsule.) The pharmacist also monitors
`child but maybe not make the treatment as comfortable fer the
`each bed-patient’s condition, checking such reactions as elec—
`trolyte imbalances. “The pharmacist can often avoid or pre-
`patient and family as possible.”W
`
`
`
`
`
`
`il
`
`i l ll1
`
`i
`
`and she had a featured role in a segment on the air this spring.
`The popular TV series then ended after 15 years “There are
`only so many rescues you can do,” Melody laughs.
`Melody1s now busy planning her wedding. She will soon
`be marrying UCLA medical student Thomas Lowe. He plans
`a career treating adults with cancer, and spends his free time
`with Melody at Camp Good Times, a camp for children with
`cancer and their families. Melody has attended the camp reg—
`ularly for years, first as a camper and now as a counselor and
`a volunteer fundraiser. The young actress also keeps busy with
`acting. dance, and singing lessons, and she performs at count—
`less auditions. Her career is very important to her.
`“Now that l’ve had a taste of the entertainment industry, I
`can’t leave it,” she says. Her mother has told her, “I didn’t
`name you Melody to have you be a social worker. You are
`meant to be a star!” Melody feels that a successful acting
`career will give her the perfect platform from which to speak
`out for kids with cancer. And she has an important message to
`convey. She says of her cancer experience, “I was so lucky. I
`have conquered odds most people don’t even face." 5:19
`
`"Baywateh Beauty" 1
`Continued item page 1
`
`Such tenacity helped her beat the
`cancer. And later she won a swimming
`scholarship to the University of
`California at Irvine. There she thought
`nothing of going to workouts six hours
`a day, while carrying 16 - 24 units. She
`planned on a Master’s Degree and
`then a career in social work. However,
`during her senior year she was bit by
`e “Show Biz Bug.”
`She took a
`drama class just to keep a friend com—
`pany, and the teacher arranged for her
`to go to New York for special training
`in musical theater.
`
`
`
`Melony was treated for
`leukemia from the age of
`six until she was nlne, ant;
`now 1s a spokesperson for
`kids with cancer.
`
`The next thing she knew she had an agent, roles in some
`commercials, and an audition for “Baywatch Hawaii.” She
`won the role of Nani. the trainee lifeguard, for five episodes,
`
`

`

`A SpecialChild
`I Meets Her Doctors
`
`in Washington
`ittle Brianna had a cancer with a big
`
`Lname: infantile acute lymphoblastic
`
`leukemia with chromosome translo-
`cation
`also known as p(4;11)q(21;23.)
`Back in 1994 when Brianna was diag—
`nosed, treatment for it had just recently
`become available.
`The chromosome
`translocation associated with this type of
`cancer was identified by the cytogenetics
`experts of the Children’s Cancer Group.
`A protocol to treat ALL in infants had just
`been developed by Dr. Gregory Reaman.
`Doctors whose work had so much
`effect on this child first met her several
`
`in Washington D.C., during
`years later,
`The March Against Cancer. When she
`went home, little Brianna told people she
`had met the doctors who saved her life.
`Brianna was the first child on this pro—
`tocol, the first child to survive this deadly
`form of leukemia.
`Just a few months old when diag—
`nosed, and breast fed during the entire
`ordeal, Brianna was in the hospital for
`119 days of intensive chemotherapy.
`“She didn’t like that at all. She wanted
`no one to touch her. She was afraid of
`everyone,” says her mother, Lyssa. She
`had a bone marrow transplant at 14
`months of age. “She never wanted to stop
`playing,” says her mother. “She would
`play for ten minutes, and then nap for an
`hour. Even when she could barely hold her
`head up she tried to play because she knew
`that was her job.”
`The family coped as best they could.
`“We kept our sense of humor," says Lyssa.
`“I laughed about things a normal person
`
`Gregory Reaman, MD — Continued from pagel
`
`cancer enrolled in clinical trials, greater
`emphasis on working with advocacy
`groups to promote the cause of children
`with cancer, and creation of a national
`childhood cancer registry.
`Dr. Reaman grew up in Akron, Ohio.
`He graduated cum laude from the
`University of Detroit, and later received
`his medical
`degree
`from Loyola
`University, Stritch School of Medicine,
`in Chicago. He completed his pediatric
`residency at
`the Montreal Children’s
`Hospital. McGill University, and his fel—
`lowship in pediatric hematologyuoncolo
`
`
`
`Institute
`the National Cancer
`gy at
`(NCl). He worked in the Pediatric
`Oncology Branch of NCI before going to
`Children’s Hospital.
`or
`authored
`has
`Dr. Reaman
`co-authored more than 170 scientific
`publications and serves on the editorial
`boards 01' the medical journals “Cancer,"
`“Journal of Pediatric Hematology-
`Oncology,” “Leukemia” and “Journal of
`Clinical Oncology.” His clinical and lab;
`oratory work includes leukemia cell
`biology, treatment of ALL in infants, and
`investigation of new anti-cancer drugs
`
`
`
`and biologics in the treatment of refrac«
`tory childhood cancer.
`Reamnn is a cancer survivor himself.
`He and his wife Susan live in Chevy
`Chase, Maryland. They are the parents of
`two daughters, Emily, 19, and Sarah, 17.
`Dr. Reanian sees the coming togeth-
`er of the Children’s Oncology Group as,
`“Taking collaboration to new heights
`a new beginning for the end of childhood
`cancer in this millennium.”
`
`See story above about Dr: Reaman and a
`speciolpatiem‘.
`‘2?
`
`
`
`
`HISTORIC MEETING — Little Brianna meets
`NCCE‘ founder G. Denman Hammond, MD, for the
`first time. While he was chair of the Children’s
`Cancer Group he implemented studies of the rare
`type of leukemia that attacks infants.
`
`PATlEh '1‘ THANKS DOCTOR -— With her face
`painted colorfully. Brianna greets Gregory Reaman,
`MD. He was the one who developed the protocol
`for infantile leukemia that was successful in
`treating her.
`
`wouldn’t laugh about. Brianna did occa-
`sionally see my anger, but 1 tried to make
`sure she had as normal an upbringing as
`possible.”
`It was several years later that Lyssa
`Bookman, who had never been to the
`nation’s capitol, had a dream. “It hit me
`in the middle of the night. I just had to
`attend The March, and take Brianna.” So
`she took her daughter out of kindergarten,
`and headed for the cancer demonstration.
`She introduced herself at the booth of the
`National Childhood Cancer Foundation
`(NCCF), and when she mentioned that
`her child had been cured of cancer she
`’was told, “Go tell that man.”
`She went
`to meet G. Denman
`Hammond, M.D.,
`the founder of NCCF.
`Dr. Hammond had been the chair of the
`Children’s Cancer Group at the time of
`Brianna’s treatments, and had implement—
`ed the studies of her
`rare type of
`leukemia. As soon as he learned how she
`had been treated in 1994, he picked her up
`and hugged her and said, “1 know all
`
`about you.” He told Lyssa that she and
`Brianna had to meet Dr. Reaman, and told
`her where to find him.
`that very moment
`Reaman was at
`speaking on a panel of cancer experts, just
`100 yards away. When a note was passed
`to him explaining that Brianna was there,
`and who she was, he just stood up in the
`middle of the discussion and left the panel
`to come and meet her.
`“I can’t believe it,” Dr. Reaman
`exclaimed, as he was finally able to put a
`face to one of the first survivors of the
`landmark protocol. Only ten children a
`year are diagnosed with that deadly type
`of cancer, and until seven years ago, near—
`ly all of them died.
`People marched in Washington that
`day, demanding that legislators appropri-
`ate more money for cancer research. A
`little girl played on the lawn near the mall
`as two doctors watched her like proud
`fathers. The point was made. Research
`Works. W
`
` 3
`
`

`

`
`
`FIRST ANNUAL Dos WALK FOR KIDS
`
`
`
`
`
`
`
`n a lovely park overlooking the Pacific Ocean, dog lovers gathered with their four—
`legged companions for the “4 Paws ForA Cure” pet walk. Organized by chairman
`Steve Gordon and a committee of fellow Viacom Productions employees, the
`event raised nearly $40,000 .
`Melissa Joan Hart, star of “Sabrina, the Teenage Witch,” was honorary chair of
`the event. The presenting sponsor was Nutro, and
`co—sponsors were Wells Fargo and Petco. Theoffi-
`cial apparel sponsor was Big Dogs.
`Young cancer survivor Carlye Gordon made the
`announcement to “Let the walk begin.” She led the
`way with her dog Lucky as a variety of purebreds
`and mutts followed the two—mile route. Watch the
`NCCF website for information on when and where
`
`
`
`
`
`Over 150 dogs took part in
`the first pet walk for NCCF. A
`
`dog and owner "look alike" cone
`test provided lots of laughs.
`
`
`the second annual pet walk will take place. ®
`
`SHE COOKS FOR A CURE
`
`PAINTINGS BENEFIT CANCER CURES
`
`Karen Calabrese challenged her New
`Jersey community: “Cook for friends
`and family, and save a child’s life!”
`She asked for volunteers to cook
`dinners in their homes, selecting what—
`ever theme or menu they Wished. The
`hostesses then sent out invitations to all
`their friends and neighbors, and charged
`$20 a person for the evening. Every host
`family was given a gift certificate so that
`they could later enjoy a night out at a
`local restaurant.
`
`While her own son is healthy, Karen
`is motivated to help the more than
`12,000 Children and young adults who
`are diagnosed with cancer each year in
`this country. She is proud that she raised
`ovcr $1,600 for NCCF. “We all should
`do whatever we can to make it possible
`to cure all of these kids," she says. £39
`
`
`
`Karen Galabrese and her son Zachery. age 6, are
`saown here having fun in the kitchen as she plans
`a series of hintiraising dinner parties.
`
`
`
`Lynn Dunbar says that for the rest of her life she will give a portion of the sale of every one
`of her paintings to benefit childhood cancer research.
`A fonner advertising art director, the artist creates bold and colorful impressionistic
`paintings, mostly landscapes. Recently one of the
`Heine Brothers
`coffee
`shops
`in Louisville,
`Kentucky, planned a showing of her paintings.
`Unlike an art gallery, they would not take a hefty
`commission on the sales. That’s when she got the
`idea. She sold seven paintings, and gave half of the
`proceeds
`to the National Childhood Cancer
`Foundation. Lynn’s son Evan was diagnosed with
`Stage IV neuroblastoma two years ago, when he
`was four. He has been treated with seven cycles of
`chemotherapy, a 4—hour opera

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket